Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29971
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorLems, W. F.-
dc.contributor.authorBours, S.-
dc.contributor.authorBergh, J. P. Vd-
dc.date.accessioned2019-11-13T14:03:00Z-
dc.date.available2019-11-13T14:03:00Z-
dc.date.issued2019-
dc.identifier.citationBEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 33(2), p. 290-300-
dc.identifier.issn1521-6942-
dc.identifier.urihttp://hdl.handle.net/1942/29971-
dc.description.abstractIn view of the high imminent risk for subsequent fractures, evaluation as early as possible after the fracture will result in early decisions about drug treatment, fall prevention and nutritional supplements. Drug treatment includes anti-resorptive and bone forming agents. Anti-resorptive therapy with broad spectrum fracture prevention and early anti-fracture effects are the first choice. In patients with multiple or severe VFs, the bone forming agent teriparatide should be considered. Adequate calcium and vitamin D are needed in all patients, together with appropriate nutrition, including adequate protein intake. (C) 2019 Elsevier Ltd. All rights reserved.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.rights2019 Elsevier Ltd. All rights reserved.-
dc.subject.otherImminent fracture risk; Drug treatment; Fall prevention: Nutrition-
dc.subject.otherImminent fracture risk; Drug treatment; Fall prevention; Nutrition-
dc.titleSecondary fracture prevention: Drug treatment, fall prevention and nutrition requirements-
dc.typeJournal Contribution-
dc.identifier.epage300-
dc.identifier.issue2-
dc.identifier.spage290-
dc.identifier.volume33-
local.format.pages11-
local.bibliographicCitation.jcatA1-
dc.description.notes[Geusens, P.; Bours, S.] Maastricht Univ, Med Ctr, CAPHRI Care & Publ Hlth Res Inst, Subdiv Rheumatol,Dept Internal Med, POB 5800, NL-6202 AZ Maastricht, Netherlands. [Geusens, P.; Bergh, J. P. Vd] Hasselt Univ, Biomed Res Ctr, Agomlaan,Gebouw D, B-3590 Diepenbeek, Belgium. [Lems, W. F.] Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands. [Bergh, J. P. Vd] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Internal Med, POB 5800, NL-6202 AZ Maastricht, Netherlands. [Bergh, J. P. Vd] VieCuri Med Ctr, Dept Internal Med, Tegelseweg 210, NL-5912 BL Venlo, Netherlands.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.berh.2019.04.005-
dc.identifier.isi000490043900007-
item.validationecoom 2020-
item.accessRightsRestricted Access-
item.fullcitationGEUSENS, Piet; Lems, W. F.; Bours, S. & Bergh, J. P. Vd (2019) Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirements. In: BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 33(2), p. 290-300.-
item.fulltextWith Fulltext-
item.contributorGEUSENS, Piet-
item.contributorLems, W. F.-
item.contributorBours, S.-
item.contributorBergh, J. P. Vd-
crisitem.journal.issn1521-6942-
crisitem.journal.eissn1521-1770-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
geusens 2.pdf
  Restricted Access		Published version351.66 kBAdobe PDFView/Open    Request a copy
Show simple item record

WEB OF SCIENCETM
Citations

3
checked on May 10, 2024

Page view(s)

94
checked on Sep 7, 2022

Download(s)

76
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.